Free Trial

GUARDCAP ASSET MANAGEMENT Ltd Has $366.59 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

UnitedHealth Group logo with Medical background
Remove Ads

GUARDCAP ASSET MANAGEMENT Ltd trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 11.9% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 724,694 shares of the healthcare conglomerate's stock after selling 98,005 shares during the period. UnitedHealth Group accounts for approximately 5.9% of GUARDCAP ASSET MANAGEMENT Ltd's holdings, making the stock its 9th largest position. GUARDCAP ASSET MANAGEMENT Ltd owned about 0.08% of UnitedHealth Group worth $366,594,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. M&T Bank Corp raised its stake in shares of UnitedHealth Group by 13.4% in the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate's stock valued at $128,975,000 after acquiring an additional 26,074 shares in the last quarter. Sugarloaf Wealth Management LLC lifted its stake in shares of UnitedHealth Group by 17.6% in the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate's stock worth $4,025,000 after buying an additional 1,193 shares during the last quarter. Benjamin Edwards Inc. grew its stake in UnitedHealth Group by 1,275.3% in the 3rd quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate's stock valued at $26,060,000 after buying an additional 41,308 shares during the last quarter. Parsifal Capital Management LP bought a new position in UnitedHealth Group during the third quarter worth $21,165,000. Finally, Signal Advisors Wealth LLC grew its position in UnitedHealth Group by 13.0% in the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate's stock worth $4,611,000 after purchasing an additional 1,051 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Analyst Upgrades and Downgrades

Several equities analysts have commented on the company. StockNews.com raised UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Thursday, January 23rd. Hsbc Global Res raised shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 10th. Truist Financial cut their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a research note on Monday, January 6th. Barclays cut their target price on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research report on Friday, January 17th. Finally, Oppenheimer increased their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an "outperform" rating in a research note on Friday, December 6th. Twenty investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Buy" and an average price target of $629.32.

View Our Latest Stock Report on UNH

UnitedHealth Group Trading Down 0.6 %

Shares of NYSE UNH traded down $2.92 during trading on Tuesday, reaching $513.58. The company had a trading volume of 3,006,004 shares, compared to its average volume of 4,898,654. The company's fifty day moving average price is $509.71 and its 200-day moving average price is $546.15. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The stock has a market cap of $469.78 billion, a P/E ratio of 33.13, a PEG ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the previous year, the business earned $5.83 earnings per share. UnitedHealth Group's revenue for the quarter was up 6.8% on a year-over-year basis. As a group, research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.64%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's payout ratio is 54.19%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the company's stock in a transaction on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares of the company's stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.33% of the company's stock.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Why Palantir’s Future Just Got a Massive Boost
Quantum Stocks Are Heating Up Again — 7 to Watch Now
Stock Market on Sale – Buy Now Before the Next Big Surge

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads